Diletta Maira
A5035066954- Hemoglobinopathies and Related Disorders
- Erythropoietin and Anemia Treatment
- COVID-19 Clinical Research Studies
- Pharmaceutical Practices and Patient Outcomes
- Liver Disease Diagnosis and Treatment
- Frailty in Older Adults
- Chronic Disease Management Strategies
- Chronic Obstructive Pulmonary Disease (COPD) Research
- COVID-19 and healthcare impacts
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Medication Adherence and Compliance
- Blood groups and transfusion
- Health Systems, Economic Evaluations, Quality of Life
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Respiratory Support and Mechanisms
- Pharmaceutical studies and practices
- Cardiovascular Function and Risk Factors
- Chronic Lymphocytic Leukemia Research
- Cardiovascular Disease and Adiposity
- Healthcare cost, quality, practices
- Heart Failure Treatment and Management
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hepatitis B Virus Studies
- Vaccine Coverage and Hesitancy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2016-2024
Azienda Ospedaliera Universitaria Senese
2023
Policlinico S.Orsola-Malpighi
2023
Ospedale San Paolo
2023
IRCCS Ospedale San Raffaele
2023
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2023
University Orthopedics Center
2021
Institute for Transfusion Medicine
2021
Ospedale Maggiore
2016-2017
University of Milan
2017
Coronavirus Disease (COVID-19) can be considered as a human pathological model of inflammation combined with hypoxia. In this setting, both erythropoiesis and iron metabolism appear to profoundly affected by inflammatory hypoxic stimuli, which act in the opposite direction on hepcidin regulation. The impact low blood oxygen levels context disease (e.g., pneumonia) has not been fully elucidated. This multicentric observational study was aimed at investigating prevalence anemia, alterations...
Chronic obstructive pulmonary disease (COPD) and heart failure (HF) mutually increase the risk of being present in same patient, especially if older. Whether or not this coexistence may be associated with a worse prognosis is debated. Therefore, employing data derived from REPOSI register, we evaluated clinical features outcomes population elderly patients admitted to internal medicine wards having COPD, HF COPD + HF.We measured socio-demographic anthropometric characteristics, severity...
Abstract Aims The association between hyperglycemia at hospital admission and relevant short- long-term outcomes in elderly population is known. We assessed the effects on mortality of hyperglycemia, disability, multimorbidity internal medicine ward patients aged ≥ 65 years. Methods Data were collected from an active register 102 geriatric wards Italy (RePoSi project). Patients recruited during four index weeks a year. Socio-demographic data, reason for hospitalization, diagnoses, treatment,...
Blood transfusion is one of the most overused procedures, especially in elderly patients. Despite current guidelines recommending a restrictive strategy stable patients, clinical practice varies according to physicians' experience and implementation patient blood management. This study aimed evaluate anemia management anemic hospitalized impact an educational program. We enrolled ≥ 65-year-old patients who presented or developed during admission tertiary hospital's internal medicine...
Diabetes is an increasing global health burden with the highest prevalence (24.0%) observed in elderly people. Older diabetic adults have a greater risk of hospitalization and several geriatric syndromes than older nondiabetic adults. For these conditions, special care required prescribing therapies including anti- diabetes drugs. Aim this study was to evaluate appropriateness adherence safety recommendations prescriptions glucose-lowering drugs hospitalized patients diabetes. Data for...